Treatment of Enteric Fever
First-Line Treatment Recommendations
For uncomplicated enteric fever, azithromycin 20 mg/kg/day (maximum 1g/day) orally for 7 days is the preferred first-line therapy, particularly in regions with high fluoroquinolone resistance such as South Asia. 1
Outpatient/Mild-Moderate Cases
- Azithromycin is the optimal choice with a 94% cure rate and significantly lower relapse risk (OR 0.09) compared to ceftriaxone 1
- Dosing: 20 mg/kg/day (maximum 1g/day) orally for 7 days 1
- This agent demonstrates lower clinical failure rates (OR 0.48) and shorter hospital stays compared to fluoroquinolones 1
Inpatient/Severe Cases
- Ceftriaxone 50-80 mg/kg/day (maximum 2g/day) intravenously for 5-7 days is the first-line therapy for hospitalized patients 2
- For adults: 1-2g every 12-24 hours based on severity 2
- Switch to oral therapy once clinical improvement occurs and temperature has been normal for 24 hours 1
Critical Diagnostic Steps
- Always obtain blood cultures before initiating antibiotics 1, 2
- For suspected sepsis, also collect stool and urine cultures 1
- Start broad-spectrum antimicrobial therapy immediately after culture collection in septic patients, then narrow based on susceptibility results 1, 2
Alternative Treatment Options Based on Resistance Patterns
When Fluoroquinolones Can Be Used (Fully Susceptible Strains Only)
- Ciprofloxacin is FDA-approved for typhoid fever caused by Salmonella typhi 3
- A 7-day course of ciprofloxacin 500mg twice daily shows 96% cure rate with rapid defervescence (median 4 days) 4
- However, over 70% of S. typhi isolates in many regions are now fluoroquinolone-resistant, making empiric use inappropriate 1, 2
- Avoid ciprofloxacin empirically for cases from South Asia due to high resistance rates 1, 2
Oral Cephalosporin Option
- Cefixime 8 mg/kg/day as a single daily dose for 7-14 days can be used as an oral alternative 1
- Adult dosing: 400mg orally once daily 1
- However, cefixime may have increased clinical failure (RR 13.39), microbiological failure (RR 4.07), and relapse (RR 4.45) compared to fluoroquinolones in susceptible strains 5
- Time to defervescence is 1.74 days longer with cefixime versus fluoroquinolones 5
Treatment Duration and Monitoring
- Most patients with uncomplicated enteric fever require 7 days of appropriate antibiotics 1
- For parenteral therapy: 5-7 days, then switch to oral as described above 1, 2
- Expected fever clearance within 4-5 days of appropriate therapy 1
Special Populations
Infants Under 3 Months
- Must use a third-generation cephalosporin (ceftriaxone) 1
Children (1-17 Years)
- Azithromycin 20 mg/kg/day for 7 days or ceftriaxone 50-80 mg/kg/day for 5-7 days 1
- Fluoroquinolones are not first-choice in pediatrics due to increased adverse events including joint-related complications 3
Comparative Effectiveness: Ceftriaxone vs. Azithromycin
- Ceftriaxone may result in decreased clinical failure compared to azithromycin (RR 0.42) 5
- Time to defervescence is 0.52 days shorter with ceftriaxone versus azithromycin 5
- However, relapse rates may be higher with ceftriaxone (RR 10.05) 5
- Both are acceptable options; choice depends on severity and route preference 1, 2
Emerging Resistance and Extensively Drug-Resistant (XDR) Strains
- XDR enteric fever has emerged in Pakistan since 2016, responding only to limited antibiotics 6
- Fluoroquinolone resistance is essentially a class effect and increasing globally 1
- Always modify therapy when susceptibility results become available 1, 2
- Local resistance patterns must guide empiric therapy selection as these vary geographically and change over time 1, 2
Common Pitfalls to Avoid
- Do not use fluoroquinolones empirically without confirmed susceptibility, especially for infections acquired in South Asia 1, 2
- Do not rely solely on clinical presentation; cultures are essential 1, 2
- Avoid premature discontinuation before complete symptom resolution 2
- Do not forget to reassess fluid and electrolyte balance in patients with persistent symptoms 1
- For persistent fever, leukocytosis, or peritoneal signs, consider CT imaging for intra-abdominal complications 2